Slides
Page 1
#0058a5 #00b1ea #f0b323#0084c8 Titel : Arial Bold Sub titel: Arial regular Text: Arial regular Colors Font Useful Tools: Add image Add video Right mouse click: Send or bring your image or shape to the front/back Home -> Arrange: Align objects Click on the graph: Click on the tab -> Change colours Q3 2026 Financial Results Conference call | October 28, 2026 www.materialise.com | NASDAQ & EURONEXT: MTLS
Page 2
#0058a5 #00b1ea #f0b323#0084c8 Titel : Arial Bold Sub titel: Arial regular Text: Arial regular Colors Font Useful Tools: Add image Add video Right mouse click: Send or bring your image or shape to the front/back Home -> Arrange: Align objects Click on the graph: Click on the tab -> Change colours Safe Harbor Summary 2 This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, among other things, our intentions, beliefs, assumptions, projections, outlook, analyses or current expectations, plans, objectives, strategies and prospects, both financial and business, including statements concerning, among other things, our estimates for revenue, Adjusted EBITDA, Adjusted EBIT, our results of operations, cash needs, capital expenditures, expenses, financial condition, liquidity, prospects, growth and strategies (including how our business, results of operations and financial condition could be impacted by the current armed geopolitical conflicts around the world and governmental responses thereto, inflation, increased labor, energy and materials costs), policy changes resulting from the U.S. presidential administration, changes in tariffs and trade restrictions, and the trends and competition that may affect the markets, industry or us. Such statements are subject to known and unknown uncertainties and risks. When used in this presentation, the words “estimate,” “expect,” “anticipate,” “project,” “plan,” “intend,” “believe,” “forecast,” “will,” “may,” “could,” “might,” “aim,” “should,” and variations of such words or similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon the expectations of management under current assumptions at the time of this presentation. These expectations, beliefs and projections are expressed in good faith and the company believes there is a reasonable basis for them. However, the company cannot offer any assurance that our expectations, beliefs and projections will actually be achieved. By their nature, forward-looking statements involve risks and uncertainties because they relate to events, competitive dynamics and industry change, and depend on economic circumstances that may or may not occur in the future or may occur on longer or shorter timelines than anticipated. We caution you that forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors that are in some cases beyond our control. All of the forward-looking statements are subject to risks and uncertainties that may cause the company's actual results to differ materially from our expectations, including risk factors described in the company's annual report on Form 20-F filed with the U.S. Securities and Exchange Commission. There are a number of risks and uncertainties that could cause the company's actual results to differ materially from the forward-looking statements contained in this presentation. This presentation includes non-IFRS financial measures, including EBIT, EBITDA, Adjusted EBIT and Adjusted EBITDA. These measures are supplemental measures of financial performance that are not required by, or presented in accordance with, international financial reporting standards (“IFRS”). Please refer to the Appendix of this presentation for a reconciliation of such non-IFRS financial measures to the most directly comparable financial measures prepared in accordance with IFRS.
Page 3
#0058a5 #00b1ea #f0b323#0084c8 Titel : Arial Bold Sub titel: Arial regular Text: Arial regular Colors Font Useful Tools: Add image Add video Right mouse click: Send or bring your image or shape to the front/back Home -> Arrange: Align objects Click on the graph: Click on the tab -> Change colours • Q3 2026 Business Highlights • Q3 2026 Financial Highlights • Q3 2026 Financial Results • 2026 Financial Guidance • Q&A Agenda Koen Berges CFO Brigitte de Vet-Veithen CEO 3
Page 4
#0058a5 #00b1ea #f0b323#0084c8 Titel : Arial Bold Sub titel: Arial regular Text: Arial regular Colors Font Useful Tools: Add image Add video Right mouse click: Send or bring your image or shape to the front/back Home -> Arrange: Align objects Click on the graph: Click on the tab -> Change colours Medtech– Scaling Access to Personalized Care • Signing partnership with Superhumans Center to support reconstructive cranio-maxillofacial surgery in Ukraine and launching innovations to support healthcare efficiencies in CMF • Expanding cardiac planning software with Valve-in-Valve capabilities • Expanding Soft Tissue surgery planning software with dedicated workflow for Liver resection Software– Growing Our Software Ecosystem • Commercial momentum for our CO-AM platform • Expanding security capabilities through the integration of CO-AM Brix and Identify3D • Gearing up for Formnext, the world's leading additive manufacturing trade show Manufacturing – Delivering Certified Additive Manufacturing Solutions • Continued growth in series manufacturing, driven by aerospace, semiconductor and defense • Expanding our metal additive manufacturing capabilities • Strong uptake of Phits Dynaprint orthotics in our Motion business Q3 2026 Business Update 4
Page 5
#0058a5 #00b1ea #f0b323#0084c8 Titel : Arial Bold Sub titel: Arial regular Text: Arial regular Colors Font Useful Tools: Add image Add video Right mouse click: Send or bring your image or shape to the front/back Home -> Arrange: Align objects Click on the graph: Click on the tab -> Change colours Q3 2026 – Financial Highlights • Revenue of 67.7 mEUR, representing an increase of 2.1% from Q3 2025 • Gross Profit of 39.0 mEUR, representing 57.7% of revenue • Adjusted EBIT of 2.5 mEUR, representing 3.7% of revenue • Net profit of 1.4 mEUR, representing 2 EUR-ct. per share • Net Cash position of 82.5 mEUR, representing an increase of 11.7 mEUR from year-end 2025, while YTD 7.5 mEUR was invested in share buybacks 5
Page 6
#0058a5 #00b1ea #f0b323#0084c8 Titel : Arial Bold Sub titel: Arial regular Text: Arial regular Colors Font Useful Tools: Add image Add video Right mouse click: Send or bring your image or shape to the front/back Home -> Arrange: Align objects Click on the graph: Click on the tab -> Change colours Q3 2026 Consolidated Revenue • Revenue of 67.7 mEUR increases by 2.1% compared to 2025. Adjusted for recent divestments revenue grows by 4.9% year-over-year • 10% revenue growth in our Medical segment while Aerospace & Defense focus areas drive growth in series manufacturing • 45.2 mEUR of deferred revenue from software licenses and maintenance carried on our balance sheet at the end of Q3 2026 Q3 2025 Q3 2026 66,259 67,670 +2.1% 15% 54% 31% Software Medical Manufacturing Q3 2026 Revenue by Segment 6 [Data in kEUR unless notes otherwise. All numbers and percentages rounded]
Page 7
#0058a5 #00b1ea #f0b323#0084c8 Titel : Arial Bold Sub titel: Arial regular Text: Arial regular Colors Font Useful Tools: Add image Add video Right mouse click: Send or bring your image or shape to the front/back Home -> Arrange: Align objects Click on the graph: Click on the tab -> Change colours Q3 2026 Consolidated Adjusted EBIT & EBITDA • Q3 2026 Adjusted EBIT and Adjusted EBITDA both end lower compared to Q3 2025 • Higher gross profit is offset by increased R&D investments and one-off indirect costs Q3 2025 Q3 2026 2,918 2,485 -14.8% 3.7%4.4% Adj. EBIT Q3 2025 Q3 2026 8,428 8,046 -4.5% 11.9%12.7% Adj. EBITDA 7 [Data in kEUR unless notes otherwise. All numbers and percentages rounded]
Page 8
#0058a5 #00b1ea #f0b323#0084c8 Titel : Arial Bold Sub titel: Arial regular Text: Arial regular Colors Font Useful Tools: Add image Add video Right mouse click: Send or bring your image or shape to the front/back Home -> Arrange: Align objects Click on the graph: Click on the tab -> Change colours Q3 2026 Medical Segment • Q3 2026 revenue increased 10% to 36.5 mEUR • Revenue from medical devices & services increased 10% • Revenue from medical software increased 10% • Q3 2026 Adjusted EBITDA landed at 10.0 mEUR, representing an Adjusted EBITDA margin of 27% Q3 2025 Q3 2026 33,296 36,542 +9.7% Q3 2025 Q3 2026 10,199 10,015 -1.8% 30.6% 27.4% Revenue Adj. EBITDA 8 [Data in kEUR unless notes otherwise. All numbers and percentages rounded]
Page 9
#0058a5 #00b1ea #f0b323#0084c8 Titel : Arial Bold Sub titel: Arial regular Text: Arial regular Colors Font Useful Tools: Add image Add video Right mouse click: Send or bring your image or shape to the front/back Home -> Arrange: Align objects Click on the graph: Click on the tab -> Change colours Q3 2026 Software Segment • Q3 2026 revenue decreased 4% to 9.9 mEUR • Recurring revenue represented 84% in Q3 2026 • Q3 2026 Adjusted EBITDA landed at 1.5 mEUR, representing an Adjusted EBITDA margin of 15% Q3 2025 Q3 2026 10,286 9,864 -4.1% Q3 2025 Q3 2026 1,801 1,463 -18.8% 17.5% 14.8% Revenue Adj. EBITDA [Data in kEUR unless notes otherwise. All numbers and percentages rounded] 9
Page 10
#0058a5 #00b1ea #f0b323#0084c8 Titel : Arial Bold Sub titel: Arial regular Text: Arial regular Colors Font Useful Tools: Add image Add video Right mouse click: Send or bring your image or shape to the front/back Home -> Arrange: Align objects Click on the graph: Click on the tab -> Change colours Q3 2026 Manufacturing Segment Q3 2025 Q3 2026 22,677 21,266 -6.2% (845) (257) Q3 2025 Q3 2026 (3.7)% (1.2)% Revenue Adj. EBITDA 10 [Data in kEUR unless notes otherwise. All numbers and percentages rounded] • Q3 2026 revenue decreased by 6% to 21.3 mEUR compared to Q3 2025. Adjusted for recent divestments revenue grows by +1% • Growth in strategic focus segments in series manufacturing is offset by lower prototyping demand compared to PY • Q3 2026 Adjusted EBITDA improved to (0.3) mEUR, representing an Adjusted EBITDA margin of (1)%
Page 11
#0058a5 #00b1ea #f0b323#0084c8 Titel : Arial Bold Sub titel: Arial regular Text: Arial regular Colors Font Useful Tools: Add image Add video Right mouse click: Send or bring your image or shape to the front/back Home -> Arrange: Align objects Click on the graph: Click on the tab -> Change colours Income Statement Highlights Q3 2026 Q3 2025 Revenue 67,670 66,259 Cost of sales (28,635) (28,608) Gross profit 39,035 37,651 Research & development expenses (12,805) (11,439) Sales & marketing expenses (15,561) (14,847) General & administrative expenses (10,464) (9,733) Other income/(expenses), net 1,137 890 Operating profit/(loss) 1,343 2,522 Financial income/(expenses), net 160 (121) Taxes (120) (553) Net profit/(loss) 1,383 1,848 Diluted EPS (in EUR) 0.02 0.03 (Diluted) weighted average shares (thousands) 58,061 59,067 11 Q3 2025 Q3 2026 56.8% 57.7% Gross profit margin (in %) Diluted EPS (in EUR) Q3 2025 Q3 2026 0.03 0.02 [Data in kEUR unless noted otherwise. All numbers and percentages rounded]
Page 12
#0058a5 #00b1ea #f0b323#0084c8 Titel : Arial Bold Sub titel: Arial regular Text: Arial regular Colors Font Useful Tools: Add image Add video Right mouse click: Send or bring your image or shape to the front/back Home -> Arrange: Align objects Click on the graph: Click on the tab -> Change colours Other Financial Highlights Balance Sheet items 30/09/26 31/12/25 Cash and equivalents 153,529 133,918 Borrowings 71,056 63,113 Net Cash 82,473 70,805 Trade receivables 48,783 54,938 Inventories 17,418 14,904 Trade payables 20,927 20,125 Deferred income 59,159 60,867 Equity 255,809 255,482 Total balance sheet 429,576 420,646 12 10,359 9,666 Q3 2025 Q3 2026 Cash flow from operations Capital expenditures (cash impact) Q3 2025 Q3 2026 5,288 2,146 [Data in kEUR unless noted otherwise. All numbers and percentages rounded]
Page 13
#0058a5 #00b1ea #f0b323#0084c8 Titel : Arial Bold Sub titel: Arial regular Text: Arial regular Colors Font Useful Tools: Add image Add video Right mouse click: Send or bring your image or shape to the front/back Home -> Arrange: Align objects Click on the graph: Click on the tab -> Change colours 2026 Financial Guidance Update Maintaining prior guidance on revenue and Adjusted EBIT • Expect 2026 consolidated revenue within 273 - 283 mEUR range • Expect 2026 consolidated Adjusted EBIT within 12 - 14 mEUR range 13
Page 14
#0058a5 #00b1ea #f0b323#0084c8 Titel : Arial Bold Sub titel: Arial regular Text: Arial regular Colors Font Useful Tools: Add image Add video Right mouse click: Send or bring your image or shape to the front/back Home -> Arrange: Align objects Click on the graph: Click on the tab -> Change colours Adjusted EBIT/EBITDA Reconciliation Appendix Q3 [Data in kEUR unless noted otherwise. All numbers and percentages rounded] 2026 2025 Net profit/(loss) 1,383 1,848 Income taxes 120 553 Financial expenses 1,128 582 Financial income (1,289) (460) EBIT 1,343 2,522 Depreciation & amortization 5,561 5,509 EBITDA 6,904 8,031 Share-based compensation expense 360 74 Restructuring and corporate initiatives 577 322 Impairments 184 - Divestitures-related expenses 22 - Adjusted EBITDA 8,046 8,428 Depreciation & amortization (5,561) (5,509) Adjusted EBIT 2,485 2,918 14
Page 15
#0058a5 #00b1ea #f0b323#0084c8 Titel : Arial Bold Sub titel: Arial regular Text: Arial regular Colors Font Useful Tools: Add image Add video Right mouse click: Send or bring your image or shape to the front/back Home -> Arrange: Align objects Click on the graph: Click on the tab -> Change colours Thank You Contact: Investor Relations Materialise investors@materialise.com 15